Stroke, A-fib recurrence low at one year after AF ablation

December 14, 2016

(HealthDay)—Stroke and atrial fibrillation (AF) recurrence are low one year after AF ablation, according to a study published online Dec. 9 in the Journal of Cardiovascular Electrophysiology.

Simon Kochhäuser, M.D., from Southlake Regional Health Centre in Newmarket, Canada, and colleagues examined the frequency of and AF recurrence in on and off therapeutic oral anticoagulation (OAC) one year after AF ablation. A total of 398 patients were identified from an AF database and were screened for AF recurrence, changes in OAC or antiarrhythmic medication, and the occurrence of stroke or .

The researchers found that OAC was discontinued in 69.3 percent of patients. During a median follow-up of 529 days, the researchers found that 1 percent of patients suffered from stroke and 13.8 percent experienced AF recurrence. The chance of AF recurrence was increased in association with persistent AF (49.1 versus 26.8 percent; P = 0.001). There was no difference in CHADS2, CHADS2-VASc-Score, or AF recurrence in patients with versus without stroke. Patients who experienced stroke had a trend toward a higher percentage of (50 versus 10 percent; P = 0.057).

"The overall risk of stroke and AF recurrence is low in patients with a recurrence free interval of at least 12 months after AF ablation," the authors write. "Of note, recurrence of AF was not associated with a higher risk of stroke in our study population."

Several authors disclosed financial ties to the pharmaceutical industry.

Explore further: A-fib recurrence common five years after ablation

More information: Full Text (subscription or payment may be required)

Related Stories

A-fib recurrence common five years after ablation

April 17, 2015

(HealthDay)—Most patients with atrial fibrillation (AF) and systolic heart failure who undergo ablation have AF recurrence at five years, according to a study published in the April issue of the Journal of Cardiovascular ...

Anakinra cuts risk of recurrence in recurrent pericarditis

November 9, 2016

(HealthDay)—Use of anakinra reduces the risk of recurrence of pericarditis among patients with recurrent pericarditis with colchicine resistance and corticosteroid dependence, according to a study published in the Nov. ...

CHADS2 best predictor of postoperative mortality risk

September 6, 2015

(HealthDay)—The CHADS2 atrial fibrillation (AF) risk score is the best predictor of postoperative stroke or death regardless of type of surgery, according to a study published online Aug. 13 in the Journal of Thrombosis ...

Ablation effectiveness quotient predicts clinical success

January 21, 2015

(HealthDay)—For patients with paroxysmal atrial fibrillation (PAF) who undergo AF ablation (AFA), a high ablation effectiveness quotient (AEQ) correlates with freedom from atrial tachyarrhythmia (AT), according to a study ...

Recommended for you

Macrophages shown to be essential to a healthy heart rhythm

April 20, 2017

A Massachusetts General Hospital (MGH)-led research team has identified a surprising new role for macrophages, the white blood cells primarily known for removing pathogens, cellular debris and other unwanted materials. In ...

3-D-printed patch can help mend a 'broken' heart

April 14, 2017

A team of biomedical engineering researchers, led by the University of Minnesota, has created a revolutionary 3D-bioprinted patch that can help heal scarred heart tissue after a heart attack. The discovery is a major step ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.